$SSII
SS Innovations International, Inc. Stock $ssii

$ssii Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024043430 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$4.386M	$6.851M	$1.363M
YoY Change	178.42%
Cost Of Revenue	$3.346M	$3.873M	$1.545M
YoY Change	147.61%	287.26%	389.32%
Gross Profit	$1.040M	$2.978M	-$181.7K
YoY Change	364.17%	482.52%	-42.44%
Gross Profit Margin	23.72%	43.46%	-13.33%
Selling, General & Admin	$3.777M	$2.611M	$15.27M
YoY Change	90.49%	84.27%	1581.57%
% of Gross Profit	363.05%	87.69%
Research & Development	$30.07K	$396.1K	$576.2K
YoY Change			689.71%
% of Gross Profit	2.89%	13.3%
Depreciation & Amortization	$333.9K	$77.19K	-$64.60K
YoY Change	8.18%	3285.48%	-2933.33%
% of Gross Profit	32.09%	2.59%
Operating Expenses	$3.808M	$5.696M	$15.85M
YoY Change	92.0%	176.89%	1515.25%
Operating Profit	-$2.767M	-$2.718M	-$16.03M
YoY Change	57.32%	75.83%	1136.04%
Interest Expense	$2.00	$183.2K	-$208.3K
YoY Change	-100.0%	170.63%	357.97%
% of Operating Profit
Other Income/Expense, Net	-$164.8K	-$80.27K	$120.0K
YoY Change	80.02%	-252.18%	-29.4%
Pretax Income	-$2.932M	-$2.798M	-$16.12M
YoY Change	58.44%	39.62%	1274.82%
Income Tax
% Of Pretax Income
Net Earnings	-$2.930M	-$2.798M	-$16.12M
YoY Change	58.34%	39.62%	1274.82%
Net Earnings / Revenue	-66.8%	-40.85%	-1182.44%
Basic Earnings Per Share	-$0.02	-$0.02
Diluted Earnings Per Share	-$0.02	-$0.02	-$0.10
COMMON SHARES
Basic Shares Outstanding	170.7M shares	170.7M shares	169.1M shares
Diluted Shares Outstanding		170.7M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.455M	$948.2K	$2.022M
YoY Change	243.85%	111.39%	49.65%
Cash & Equivalents	$1.455M	$948.2K	$2.022M
Short-Term Investments
Other Short-Term Assets	$10.12M	$8.450M	$8.386M
YoY Change	631.61%	97255.18%	96511.75%
Inventory	$6.443M	$6.162M	$6.327M
Prepaid Expenses
Receivables	$4.604M	$4.226M	$1.647M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$22.62M	$19.79M	$18.38M
YoY Change	312.42%	262.58%	321.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.024M	$2.062M	$790.2K
YoY Change	363.6%	22505.22%	6831.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.659M		$0.00
YoY Change
Total Long-Term Assets	$15.69M	$11.26M	$7.096M
YoY Change	272.97%	123345.91%	62154.46%
TOTAL ASSETS
Total Short-Term Assets	$22.62M	$19.79M	$18.38M
Total Long-Term Assets	$15.69M	$11.26M	$7.096M
Total Assets	$38.32M	$31.05M	$25.48M
YoY Change	295.3%	467.93%	482.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.295M	$1.446M	$900.9K
YoY Change	3977.47%
Accrued Expenses	$4.273M	$5.553M	$2.330M
YoY Change	100.52%	97325.44%	40783.51%
Deferred Revenue			$156.3K
YoY Change
Short-Term Debt	$12.16M	$8.657M	$6.019M
YoY Change	96.46%	73.14%	50.47%
Long-Term Debt Due			$0.00
YoY Change
Total Short-Term Liabilities	$17.73M	$15.66M	$9.271M
YoY Change	111.73%	205.99%	128.84%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.609M	$1.846M	$1.910M
YoY Change	621.84%
Total Long-Term Liabilities	$3.609M	$1.846M	$1.910M
YoY Change	621.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.73M	$15.66M	$9.271M
Total Long-Term Liabilities	$3.609M	$1.846M	$1.910M
Total Liabilities	$21.33M	$17.51M	$11.18M
YoY Change	140.48%	242.06%	175.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$32.01M	-$38.13M	-$35.33M
YoY Change	67.57%	200.33%	230.46%
Common Stock	$17.07K	$17.07K	$17.07K
YoY Change	16.82%	160.9%	216.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.98M	$13.54M	$14.30M
YoY Change
Total Liabilities & Shareholders Equity	$38.32M	$31.05M	$25.48M
YoY Change	295.3%	467.93%	482.85%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$2.930M	-$2.798M	-$16.12M
YoY Change	58.34%	39.62%	1274.82%
Depreciation, Depletion And Amortization	$333.9K	$77.19K	-$64.60K
YoY Change	8.18%	3285.48%	-2933.33%
Cash From Operating Activities	-$3.433M	$1.338M	$258.3K
YoY Change	-66.81%	-497.51%	-122.81%
INVESTING ACTIVITIES
Capital Expenditures	$171.0K	$1.317M	$1.886M
YoY Change	-76.76%
Acquisitions
YoY Change
Other Investing Activities	$259.7K	-$2.890M	$4.533M
YoY Change	-78.86%	44.52%	-338.6%
Cash From Investing Activities	$88.65K	-$4.208M	$2.647M
YoY Change	-82.0%	110.38%	-239.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.500M	$2.740M	-7.288M
YoY Change	-64.37%	91.06%	-288.35%
NET CHANGE
Cash From Operating Activities	-3.433M	$1.338M	258.3K
Cash From Investing Activities	88.65K	-$4.208M	2.647M
Cash From Financing Activities	3.500M	$2.740M	-7.288M
Net Change In Cash	156.2K	-$129.9K	-4.382M
YoY Change	-712.79%	-85.61%	-623.4%
FREE CASH FLOW
Cash From Operating Activities	-$3.433M	$1.338M	$258.3K
Capital Expenditures	$171.0K	$1.317M	$1.886M
Free Cash Flow	-$3.604M	$21.06K	-$1.628M
YoY Change	-67.47%	-106.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	405, 3rd Floor
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	iLabs Info Technology Centre
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Gurugram, Haryana
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	122016
CY2024Q1	dei	Entity Address Country EntityAddressCountry	IN
CY2024Q1	dei	City Area Code CityAreaCode	+91
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	73375 53469
CY2024Q1	dei	Security12b Title Security12bTitle	None
CY2024Q1	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	170739381	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	948152	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2022276	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	5954970	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5010725	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4226144	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1647274	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	6162235	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6327256	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2495457	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3375169	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	19786958	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	18382700	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2061596	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	790164	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2127769	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2199418	usd
CY2024Q1	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	5659347	usd
CY2023Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2640342	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	11258267	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	7096386	usd
CY2024Q1	us-gaap	Assets Assets	31045225	usd
CY2023Q4	us-gaap	Assets Assets	25479086	usd
CY2024Q1	us-gaap	Bank Overdrafts BankOverdrafts	6207185	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	6018926	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	2450000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	281380	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	288988	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1446218	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	900903	usd
CY2024Q1	ssii	Deferred Tax Liability Current DeferredTaxLiabilityCurrent	6582	usd
CY2023Q4	ssii	Deferred Tax Liability Current DeferredTaxLiabilityCurrent	20482	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5271874	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2041372	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	15663238	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9270670	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1846389	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1910432	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1846389	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1910432	usd
CY2024Q1	us-gaap	Liabilities Liabilities	17509627	usd
CY2023Q4	us-gaap	Liabilities Liabilities	11181102	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	170739381	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	170739381	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	170711881	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	170711881	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	17073	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	17071	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5000	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2024Q1	ssii	Translation Adjustment TranslationAdjustment	331489	usd
CY2023Q4	ssii	Translation Adjustment TranslationAdjustment	329100	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	51077789	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49039341	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	899917	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	899917	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38127694	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35329246	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	13535597	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14297984	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31045224	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25479086	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	3873339	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1000204	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	2977720	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	511175	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	396050	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1955	usd
CY2024Q1	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	1937202	usd
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	1592309	usd
CY2024Q1	us-gaap	Salaries And Wages SalariesAndWages	674436	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	357674	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2611019	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1490414	usd
CY2024Q1	us-gaap	Depreciation Depreciation	77189	usd
CY2023Q1	us-gaap	Depreciation Depreciation	31675	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	5695897	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3474027	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2718177	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2962852	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	183212	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	102941	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29510	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-80271	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	29510	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2798448	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2992362	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2798448	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2992362	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2024Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	170738204	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	61710861	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2798448	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2992362	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2389	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2800837	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2992362	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14297984	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1937202	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	101249	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-2389	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2798448	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	13535597	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2460547	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	432672	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1597693	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1156	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2992362	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-3421388	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2798448	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2992362	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	45725	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2279	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2389	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1937201	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1597693	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1534137	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3697874	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1218838	usd
CY2024Q1	ssii	Right Of Use Liability Current Portion RightOfUseLiabilityCurrentPortion	7608	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1338218	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-173553	usd
CY2023Q1	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	2000000	usd
CY2024Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	3019005	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1317157	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	71649	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4207606	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2000000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	188259	usd
CY2024Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2450000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	101249	usd
CY2023Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	446188	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	12360	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2739507	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1433828	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-129881	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-739724	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7033001	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1351364	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6903120	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	611640	usd
CY2024Q1	ssii	Working Capital Deficit WorkingCapitalDeficit	4123720	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2798448	usd
CY2024Q1	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	2450000	usd
CY2024Q1	ssii	Convertible Promissory Notes Issued Percentage ConvertiblePromissoryNotesIssuedPercentage	0.07	pure
CY2024Q1	ssii	Accrued Interest Percentage AccruedInterestPercentage	0.07	pure
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and expenses. The Company regularly evaluates estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates made by management.</p>
CY2024Q1	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	83.31	pure
CY2024Q1	us-gaap	Inventory Net InventoryNet	6162235	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Concentration of Credit Risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its principal cash balance in United States financial institutions, where deposits are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. The Company also maintains cash balances maintained with banks in India, where balances are insured by Deposit Insurance and Credit Guarantee Corporation of India (DICGC) to the extent of approximately US$ 6,100 per account and in the Bahamas, where deposits are insured by the Deposit Insurance Corporation of Bahamas insures deposits up to US$50,000 per account. As at March 31, 2024, deposits of $609,076 were in excess of overall insurance coverage limits.</p>
CY2024Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2024Q1	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	6100	usd
CY2024Q1	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	50000	usd
CY2024Q1	us-gaap	Payments For Deposits PaymentsForDeposits	609076	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2041372	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6718091	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2942275	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1446218	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	900903	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5271874	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2524014	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1213596	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	462418	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	423432	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2061596	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	790164	usd
CY2024Q1	us-gaap	Depreciation Depreciation	77189	usd
CY2023Q1	us-gaap	Depreciation Depreciation	31675	usd
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4226144	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1647274	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4226144	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1647274	usd
CY2024Q1	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	5659347	usd
CY2023Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2640342	usd
CY2024Q1	us-gaap	Other Long Term Investments OtherLongTermInvestments	9885492	usd
CY2023Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	4287616	usd
CY2024Q1	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	5659347	usd
CY2024Q1	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	2450000	usd
CY2024Q1	ssii	Convertible Promissory Notes Issued Percentage ConvertiblePromissoryNotesIssuedPercentage	0.07	pure
CY2024Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	4.45
CY2024Q1	us-gaap	Bank Overdrafts BankOverdrafts	6207185	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	6018926	usd
CY2024Q1	us-gaap	Deposits Deposits	5553119	usd
CY2024Q1	ssii	Percentage Of Common Stock Issued And Outstanding PercentageOfCommonStockIssuedAndOutstanding	0.95	pure
CY2024Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3000000	usd
CY2024Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	5
CY2024Q1	ssii	Options To The Extent Vested Expire Term OptionsToTheExtentVestedExpireTerm	P5Y
CY2024Q1	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	1829.25	usd
CY2019Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	2454.75	usd
CY2019Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2223	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1474.17	usd
CY2022Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	404.68	usd
CY2024Q1	ssii	Monthly Space Rent MonthlySpaceRent	194	usd
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	16528	usd
CY2024Q1	ssii	Lease Expiration Date LeaseExpirationDate	March 2030
CY2023Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
CY2023Q2	us-gaap	Area Of Land AreaOfLand	21600	sqft
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	12033	usd
CY2024Q1	us-gaap	Other Loans Payable OtherLoansPayable	1409555	usd
CY2023Q4	us-gaap	Other Loans Payable OtherLoansPayable	1466463	usd
CY2024Q1	us-gaap	Loans Payable LoansPayable	1409555	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	1466463	usd
CY2024Q1	ssii	Convertible Promissory Notes Issued Value ConvertiblePromissoryNotesIssuedValue	2450000	usd
CY2024Q1	ssii	Convertible Promissory Notes Issued Percentage ConvertiblePromissoryNotesIssuedPercentage	0.07	pure
CY2024Q1	ssii	Accrued Interest Percentage AccruedInterestPercentage	0.07	pure
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q1	us-gaap	Interest Expense InterestExpense		usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	170738204	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61710861	shares
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod		usd
CY2024Q1	ssii	Stock Issued During Period Value Accumulated Other Comprehensive Loss StockIssuedDuringPeriodValueAccumulatedOtherComprehensiveLoss		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
CY2023Q1	ssii	Right Of Use Liability Current Portion RightOfUseLiabilityCurrentPortion		usd
CY2024Q1	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition		usd
CY2023Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable		usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts		usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2024Q1	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants		usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001676163

Files In Submission

Name	View Source	Status
0001213900-24-043430-index-headers.html	Edgar Link	pending
0001213900-24-043430-index.html	Edgar Link	pending
0001213900-24-043430.txt	Edgar Link	pending
0001213900-24-043430-xbrl.zip	Edgar Link	pending
ea0205873-10q_ssinnova.htm	Edgar Link	pending
ea020587301ex31-1_ssinnova.htm	Edgar Link	pending
ea020587301ex31-2_ssinnova.htm	Edgar Link	pending
ea020587301ex32-1_ssinnova.htm	Edgar Link	pending
ea020587301ex32-2_ssinnova.htm	Edgar Link	pending
ea0205873-10q_ssinnova_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssii-20240331.xsd	Edgar Link	pending
ssii-20240331_def.xml	Edgar Link	unprocessable
ssii-20240331_lab.xml	Edgar Link	unprocessable
ssii-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ssii-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSII
SS Innovations International, Inc. Stock $ssii

2024 Q2 Form 10-Q Financial Statement

#000121390024043430 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSII SS Innovations International, Inc. Stock $ssii

2024 Q2 Form 10-Q Financial Statement

#000121390024043430 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSII
SS Innovations International, Inc. Stock $ssii